Search Results - "EGBERTS, A. C. G"

Refine Results
  1. 1
  2. 2

    Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT by van Geijlswijk, Ingeborg M., van der Heijden, Kristiaan B., Egberts, A. C. G., Korzilius, Hubert P. L. M., Smits, Marcel G.

    Published in Psychopharmacologia (01-10-2010)
    “…Rationale Pharmacokinetics of melatonin in children might differ from that in adults. Objectives This study aims to establish a dose–response relationship for…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study by Pouwels, S, van Staa, T. P, Egberts, A. C. G, Leufkens, H. G. M, Cooper, C, de Vries, F

    Published in Osteoporosis international (01-09-2009)
    “…Summary This case-control study showed that current use of conventional antipsychotics, but not atypical antipsychotics, seems to be associated with an…”
    Get full text
    Journal Article
  5. 5

    Use of anti-depressants and the risk of fracture of the hip or femur by van den Brand, M. W. M, Samson, M. M, Pouwels, S, van Staa, T. P, Thio, B, Cooper, C, Leufkens, H. G. M, Egberts, A. C. G, Verhaar, H. J. J, de Vries, F

    Published in Osteoporosis international (01-10-2009)
    “…Summary Anti-depressants are used largely, but have serious side effects. We show that both selective serotonin re-uptake inhibitors (SSRIs) and tricyclic…”
    Get full text
    Journal Article
  6. 6

    Monitoring of patients treated with lithium for bipolar disorder: an international survey by Nederlof, M., Heerdink, E. R., Egberts, A. C. G., Wilting, I., Stoker, L. J., Hoekstra, R., Kupka, R. W.

    Published in International Journal of Bipolar Disorders (14-04-2018)
    “…Background Adequate monitoring of patients using lithium is needed for optimal dosing and for early identification of patients with (potential) ADEs. The…”
    Get full text
    Journal Article
  7. 7

    Quantifying antibiotic use in paediatrics: a proposal for neonatal DDDs by Liem, T. B. Y, Heerdink, E. R, Egberts, A. C. G, Rademaker, C. M. A

    “…The defined daily dose (DDD) as defined by the World Health Organization (WHO) has been the most frequently used unit of measurement to measure antibiotic use…”
    Get full text
    Journal Article
  8. 8

    Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study by Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F.

    Published in Osteoporosis international (01-07-2011)
    “…Summary The effect of dopaminergic medication on the risk of hip/femur fractures is not clear. Our results showed a nearly twofold increased risk of hip/femur…”
    Get full text
    Journal Article
  9. 9

    Antidepressant use before and after initiation of diabetes mellitus treatment by Knol, M. J, Geerlings, M. I, Grobbee, D. E, Egberts, A. C. G, Heerdink, E. R

    Published in Diabetologia (01-03-2009)
    “…Aims/hypothesis Although current literature suggests an association between diabetes and depression, the direction of the association is unclear. We examined…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system by VAN GEFFEN, E. C. G, VAN DER WAL, S. W, VAN HULTEN, R, DE GROOT, M. C. H, EGBERTS, A. C. G, HEERDINK, E. R

    Published in European journal of clinical pharmacology (01-12-2007)
    “…To assess experiences related to antidepressant use reported to an internet-based medicine reporting system and to compare the nature of the side effects…”
    Get full text
    Journal Article
  12. 12

    The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors by Vlieland, N. D., Nejadnik, M. R., Gardarsdottir, H., Romeijn, S., Sediq, A. S., Bouvy, M. L., Egberts, A. C. G., van den Bemt, B. J. F., Jiskoot, W.

    Published in Pharmaceutical research (01-02-2018)
    “…Purpose To measure aggregate and particle formation in tumor necrosis factor-alpha (TNF-α) inhibitors etanercept, adalimumab and certolizumab pegol product…”
    Get full text
    Journal Article
  13. 13

    Indications for antidepressant drug prescribing in general practice in the Netherlands by Gardarsdottir, H, Heerdink, E.R, van Dijk, L, Egberts, A.C.G

    Published in Journal of affective disorders (01-02-2007)
    “…Abstract Background The intensity of the use of antidepressants in large populations can nowadays relatively easily be estimated using databases encompassing…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Risk Management Plans as a Tool for Proactive Pharmacovigilance: A Cohort Study of Newly Approved Drugs in Europe by Vermeer, N S, Duijnhoven, R G, Straus, S M J M, Mantel-Teeuwisse, A K, Arlett, P R, Egberts, A C G, Leufkens, H G M, De Bruin, M L

    Published in Clinical pharmacology and therapeutics (01-12-2014)
    “…Risk Management Plans (RMPs) have become a cornerstone in the pharmacovigilance of new drugs in Europe. The RMP was introduced in 2005 to support a proactive…”
    Get full text
    Journal Article
  17. 17

    Risk of ischemic complications related to the intensity of triptan and ergotamine use by WAMMES-VAN DER HEIJDEN, E. A, RAHIMTOOLA, H, LEUFKENS, H. G. M, TIJSSEN, C. C, EGBERTS, A. C. G

    Published in Neurology (10-10-2006)
    “…To investigate whether the intensity of triptan and ergotamine use, in specific overuse, is associated with the risk of ischemic complications. We conducted a…”
    Get full text
    Journal Article
  18. 18

    Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial by Klop, C., de Vries, F., Vinks, T., Kooij, M. J., van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., Bouvy, M. L.

    Published in Osteoporosis international (01-01-2014)
    “…Summary The aim of this study was to determine whether feedback by pharmacists to prescribers of patients eligible for glucocorticoid-induced osteoporosis…”
    Get full text
    Journal Article
  19. 19

    VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement by Schalekamp, T, Brassé, B P, Roijers, J F M, Meegen, E, Meer, F J M, Wijk, E M, Egberts, A C G, Boer, A

    Published in Clinical pharmacology and therapeutics (01-02-2007)
    “…In a prospective follow‐up study of the effects of VKORC1 and CYP2C9 genotypes on the anticoagulation status of patients, we assessed the CYP2C9 and the VKORC1…”
    Get full text
    Journal Article
  20. 20

    Prevalence and determinants of pharmacy shopping behaviour by Buurma, H., Bouvy, M. L., De Smet, P. A. G. M., Floor-Schreudering, A., Leufkens, H. G. M., Egberts, A. C. G.

    “…Summary Background and objective:  Discontinuity of care bears the risk of medication errors and poor clinical outcomes. Little is known about the continuity…”
    Get full text
    Journal Article